Home > Insider Trading > Filing (0001246360-14-000472)

Filing Details

Accession Number:: 0001246360-14-000472
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-01-30 17:42:09
Reporting Period:: 2014-01-28

Filing Date:: 2014-01-30
Accepted Time:: 2014-01-30 17:42:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
911326	Synageva Biopharma Corp	GEVA	Biological Products, (No Disgnostic Substances) (2836)	561808663

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1532218	K Sanj Patel	33 Hayden Ave Lexington MA 02421	President & Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-01-28	6,106	$0.95	7,137	No	4	M	Direct
Common Stock	Acquisiton	2014-01-28	24,832	$3.52	31,969	No	4	M	Direct
Common Stock	Acquisiton	2014-01-28	20,391	$1.70	52,360	No	4	M	Direct
Common Stock	Disposition	2014-01-28	9,506	$87.16	42,854	No	4	S	Direct
Common Stock	Disposition	2014-01-28	32,609	$88.38	10,245	No	4	S	Direct
Common Stock	Disposition	2014-01-28	8,402	$88.95	1,843	No	4	S	Direct
Common Stock	Disposition	2014-01-28	812	$90.10	1,031	No	4	S	Direct
Common Stock	Acquisiton	2014-01-29	50,971	$3.52	52,002	No	4	M	Direct
Common Stock	Disposition	2014-01-29	24,817	$87.19	27,185	No	4	S	Direct
Common Stock	Disposition	2014-01-29	18,652	$88.31	8,533	No	4	S	Direct
Common Stock	Disposition	2014-01-29	5,600	$89.27	2,933	No	4	S	Direct
Common Stock	Disposition	2014-01-29	1,502	$90.85	1,431	No	4	S	Direct
Common Stock	Disposition	2014-01-29	400	$91.58	1,031	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2014-01-28	24,832	$0.00	24,832	$3.52
Common Stock	Stock Option (Right to Buy)	Disposition	2014-01-28	6,106	$0.00	6,106	$0.95
Common Stock	Stock Option (Right to Buy)	Disposition	2014-01-28	20,391	$0.00	20,391	$1.70
Common Stock	Stock Option (Right to Buy)	Disposition	2014-01-29	50,971	$0.00	50,971	$3.52

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
55,987	2018-09-24	No	4	M	Direct
0	2019-12-15	No	4	M	Direct
36,048	2021-05-25	No	4	M	Direct
5,016	2018-09-24	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	286	Indirect	Held by Abbey Road Investment Group

Footnotes

The stock option exercise and sale of shares of common stock ("Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on October 31, 2013.
The reporting person was granted two options on 09/24/2008. These options are combined for reporting purposes herein. The first option was to purchase 99,017 Shares. 25% of such Shares vested and became exercisable on 6/23/2009, and 1/36 of the remainder of such Shares vested and became exercisable monthly thereafter. The second was an option to purchase 33,005 Shares. 25% of such Shares vested and became exercisable on 9/24/2010, and 1/36 of the remainder of such Shares vested and became exercisable monthly thereafter.
The stock option granted the reporting person an option to purchase 117,220 Shares. 25% of such Shares vested and became exercisable on 09/25/2010, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter.
The stock option granted the reporting person an option to purchase 108,052 Shares. 25% of such Shares vested and became exercisable on 5/25/2012, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $86.70 to $87.64. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $87.75 to $88.73. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $88.75 to $89.72. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $89.92 to $90.21. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $86.82 to $87.80. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $87.83 to $88.80. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $89.00 to $89.66. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $90.49 to $91.36. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.